These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 1692866)
1. Structure of an epitope in an immunodominant region of the interferon-gamma molecule that is involved in receptor interaction. Jarpe MA; Johnson HM J Interferon Res; 1990 Apr; 10(2):243-52. PubMed ID: 1692866 [TBL] [Abstract][Full Text] [Related]
2. Use of synthetic peptides to identify an N-terminal epitope on mouse gamma interferon that may be involved in function. Magazine HI; Carter JM; Russell JK; Torres BA; Dunn BM; Johnson HM Proc Natl Acad Sci U S A; 1988 Feb; 85(4):1237-41. PubMed ID: 2448795 [TBL] [Abstract][Full Text] [Related]
3. Characterization of a synthetic peptide corresponding to a receptor binding domain of mouse interferon gamma. Magazine HI; Johnson HM Biochemistry; 1991 Jun; 30(23):5784-9. PubMed ID: 1828370 [TBL] [Abstract][Full Text] [Related]
4. Topology of receptor binding domains of mouse IFN-gamma. Jarpe MA; Johnson HM J Immunol; 1990 Nov; 145(10):3304-9. PubMed ID: 1700005 [TBL] [Abstract][Full Text] [Related]
5. Epitope and functional specificity of monoclonal antibodies to mouse interferon-gamma: the synthetic peptide approach. Russell JK; Hayes MP; Carter JM; Torres BA; Dunn BM; Russell SW; Johnson HM J Immunol; 1986 May; 136(9):3324-8. PubMed ID: 2420886 [TBL] [Abstract][Full Text] [Related]
6. Epitope Mapping of Neutralizing Monoclonal Antibodies to Human Interferon-γ Using Human-Bovine Interferon-γ Chimeras. Zuber B; Rudström K; Ehrnfelt C; Ahlborg N J Interferon Cytokine Res; 2016 Sep; 36(9):542-51. PubMed ID: 27336613 [TBL] [Abstract][Full Text] [Related]
7. Functional analysis of interferon-alpha subtypes using monoclonal antibodies to interferon-alpha 4a--subtype reactivity, neutralisation of biological activities and epitope analysis. Overall ML; Hertzog PJ Mol Immunol; 1992 Mar; 29(3):391-9. PubMed ID: 1372957 [TBL] [Abstract][Full Text] [Related]
8. Human interferon-gamma receptor. Mapping of epitopes recognized by neutralizing antibodies using native and recombinant receptor proteins. Garotta G; Ozmen L; Fountoulakis M; Dembic Z; van Loon AP; Stüber D J Biol Chem; 1990 Apr; 265(12):6908-15. PubMed ID: 1691178 [TBL] [Abstract][Full Text] [Related]
9. Steric relationship of amino-terminal and carboxy-terminal domains of murine interferon-gamma as assessed by monoclonal antibodies. Russell JK; Magazine HI; Torres BA; Johnson HM J Interferon Res; 1988 Aug; 8(4):433-9. PubMed ID: 3139782 [TBL] [Abstract][Full Text] [Related]
10. A crystalline synthetic peptide representing the epitope of a monoclonal antibody raised against synthetic interferon-alpha 1 fragment 111-166. Aguet M; Salgam P; Gutte B; Arnheiter H Eur J Biochem; 1985 Feb; 146(3):689-91. PubMed ID: 2578959 [TBL] [Abstract][Full Text] [Related]
12. Epitopes of human interferon-alpha defined by the reaction of monoclonal antibodies with alpha interferons and interferon analogues. Taylor-Papadimitriou J; Shearer M; Griffin D J Immunol; 1987 Nov; 139(10):3375-81. PubMed ID: 2445813 [TBL] [Abstract][Full Text] [Related]
13. Synthetic mimics of juxtaposed amino- and carboxyl-terminal peptide domains of human gamma interferon block ligand binding to human gamma interferon receptor. Seelig GF; Prosise WW; Taremi SS J Biol Chem; 1994 Jan; 269(1):358-63. PubMed ID: 7506256 [TBL] [Abstract][Full Text] [Related]
14. Identification of a linear epitope of interferon-alpha2b recognized by neutralizing monoclonal antibodies. Blank VC; Sterin-Prync A; Retegui L; Vidal A; Criscuolo M; Roguin LP Eur J Biochem; 1999 Oct; 265(1):11-9. PubMed ID: 10491153 [TBL] [Abstract][Full Text] [Related]
15. Antibodies that neutralize human beta interferon biologic activity recognize a linear epitope: analysis by synthetic peptide mapping. Redlich PN; Hoeprich PD; Colby CB; Grossberg SE Proc Natl Acad Sci U S A; 1991 May; 88(9):4040-4. PubMed ID: 1708891 [TBL] [Abstract][Full Text] [Related]
16. Reduced receptor binding by a human interferon-gamma fragment lacking 11 carboxyl-terminal amino acids. Leinikki PO; Calderon J; Luquette MH; Schreiber RD J Immunol; 1987 Nov; 139(10):3360-6. PubMed ID: 2960733 [TBL] [Abstract][Full Text] [Related]
17. Immunodominant structures in the aminoterminal portion of human interferon alpha 1. Kontsek P; Borecký L; Kontseková E; Kolcunová A; Novák M; Zav'yalov VP; Maiorov VA Mol Immunol; 1992; 29(7-8):863-70. PubMed ID: 1378930 [TBL] [Abstract][Full Text] [Related]
18. Human interferon-gamma has three domains associated with its antiviral function: a neutralizing epitope typing scheme for human interferon-gamma. Kwok AY; Zu X; Yang C; Alfa MJ; Jay FT Immunology; 1993 May; 79(1):131-7. PubMed ID: 7685313 [TBL] [Abstract][Full Text] [Related]
19. Stable conformation of an interferon-gamma receptor binding peptide in aqueous solution is required for interferon-gamma antagonist activity. Jarpe MA; Johnson HM J Interferon Res; 1993 Apr; 13(2):99-103. PubMed ID: 8509661 [TBL] [Abstract][Full Text] [Related]
20. Three separate epitopes on human IFN-alpha variants defined by monoclonal antibodies and their role in the binding to receptors. Kandefer-Szerszeń M; Lundgren E Arch Immunol Ther Exp (Warsz); 1992; 40(3-4):241-6. PubMed ID: 1284462 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]